Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CardioFocus brings in $30.6mm through its Series D venture round

Executive Summary

CardioFocus Inc. (atrial fibrillation transcatheter treatment) has raised $30.6mm through the closing of its Series D venture round. New backers Fletcher Spaght Ventures, Manatuck Hill Partners, and First Alliance & Capital Invest were joined by previous shareholders SV Life Sciences, HIG BioVentures, Accuitive Medical Ventures, the Aurora Funds, Oxford Bioscience Partners, Kestrel Venture Management, and KBL Healthcare Investors. The company will use the funds to continue marketing its endoscopic ablation system in Europe and begin a US IDE pivotal study.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies